None listed
Conditions
Interventions
Medical Device : The treatment is to attach MEMO Patch2 and MEMO Gateway after training on how to use them, monitor with them for 14 days, return them to the site by mail, and check the results. The c
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Participant aged 19 years or older at the time of informed consent who voluntarily agrees to participate, and signs informed consent form in the study 2) Participant who need external ECG monitoring
Exclusion criteria
Exclusion criteria: 1) Participant who are not suitable for the study or may increase risk because determined by the investigator 2) Participant with skin diseases such as sensitive or allergic skin, skin cancer, rash etc. 3) Participant with pacemaker, implantable cardioverter defibrillator (ICD) or another implantable electrical device. 4) Participant who is judged to have difficulty understanding information about the meaning and making decision voluntarily due to cognitive vulnerability. 5) Participant who are determined by the investigator to be inappropriate for participation in the study because it may affect the results of the study or ethically.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The detection rate of atrial Fibrillation | — |
Secondary
| Measure | Time frame |
|---|---|
| Accuracy of atrial fibrillation remote alarm (%);Early diagnostic date of atrial fibrillation via remote alarm;Major arrhythmia detection rate excluding atrial fibrillation;Arrhythmia detection rate by attachment date with MEMO Patch2;The evaluation of usability | — |
Countries
Korea, Republic of
Contacts
Public ContactMyoungEun Kim
Asan Medical Center
Outcome results
None listed